Outreach Core for Systems Immuno-Oncology in Melanoma and Solid Tumors
Official title: Outreach Core
Funded at Institute for Systems Biology · NIH-11415807 · Data updated 2026-11-12
A national outreach program supports patient-facing education and internships while advancing personalized immunotherapy strategies for solid tumors like melanoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Institute for Systems Biology NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 22, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $416,279 |
| NIH project number | 5U54CA274509-05 |
| Project ID | NIH-11415807 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are patients with solid tumors, especially melanoma, who might benefit from future translational advances or participate in related educational programs and clinical trials.
✕Less likely to help
Patients seeking immediate clinical trials or direct treatment changes from this grant may not see direct benefits in the short term.
What this research studies
This grant funds a combined science and education effort that links experimental and computational work to optimize sequential immunotherapy with targeted inhibitors for solid tumors. It also runs a robust outreach component to train students and teachers in systems biology and immuno-oncology, integrating education with ongoing research. The program collaborates with the Institute for Systems Biology to connect real-world cancer research with classroom experiences and future patient-facing opportunities.
Why it matters
Potential benefit: If successful, the project could improve how immunotherapy is taught to students and may accelerate translation of personalized treatment concepts for melanoma and other solid tumors.
How similar studies have gone: Previous education-focused translational efforts have shown improved engagement and comprehension in STEM while supporting cancer research advances.
Where this research is happening
-
Institute for Systems Biology
Seattle, United States Active
Researchers
- Principal investigator: Ludwig, Claudia — Institute for Systems Biology
- Study coordinator: Ludwig, Claudia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.